Analysis of the total lyso-CDH revealed a significant increase in the median levels of lyso-CDH by 5.9- and 2.0-fold in GD and FD patients, respectively, when compared with healthy controls (Figure 4B). This evidence concerns the gene CHDH and Fabry disease.